RheaVita Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
6
RheaVita General Information
Description
Developer of a continuous freeze-drying technology designed to improve pharmaceutical manufacturing processes. The company's platform includes advanced lyophilization methods, rapid formulation development, and compliant production systems, enabling pharmaceutical companies to enhance efficiency and overcome limitations of batch processing.
Contact Information
Website
www.rheavita.comCorporate Office
- Poortakkerstraat 9C
- 9051 Gent
- Belgium
Corporate Office
- Poortakkerstraat 9C
- 9051 Gent
- Belgium
RheaVita Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | 01-Jan-2026 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | 18-Nov-2024 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 02-Jun-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jan-2018 | Completed | Startup |
RheaVita Patents
RheaVita Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026224317-A1 | Method and device for spin freezing | Pending | 23-Apr-2025 | ||
| EP-4453491-A1 | Device and method for freeze-drying liquid-containing composition | Pending | 22-Dec-2021 | ||
| WO-2023118392-A1 | Device and method for freeze-drying liquid-containing composition | Inactive | 22-Dec-2021 | ||
| US-20250060159-A1 | Device and method for freeze-dryng liquid-containing composition | Pending | 22-Dec-2021 | ||
| AU-2021373282-A1 | Method and apparatus for freezing or thawing mixtures comprising water | Active | 04-Nov-2020 | F26B5/06 |
RheaVita Signals
RheaVita Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Innovation Council | Accelerator/Incubator | |||
| Industria Macchine Automatiche | PE-Backed Company | Minority | ||
| Novalis Biotech | Venture Capital | Minority | ||
| PMV (Belgium) | Asset Manager | Minority | ||
| Ghent University | University |
RheaVita FAQs
-
When was RheaVita founded?
RheaVita was founded in 2018.
-
Where is RheaVita headquartered?
RheaVita is headquartered in Gent, Belgium.
-
What is the size of RheaVita?
RheaVita has 13 total employees.
-
What industry is RheaVita in?
RheaVita’s primary industry is Other Devices and Supplies.
-
Is RheaVita a private or public company?
RheaVita is a Private company.
-
What is RheaVita’s current revenue?
The current revenue for RheaVita is .
-
How much funding has RheaVita raised over time?
RheaVita has raised $3.04M.
-
Who are RheaVita’s investors?
European Innovation Council, Industria Macchine Automatiche, Novalis Biotech, PMV (Belgium), and Ghent University are 5 of 6 investors who have invested in RheaVita.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process